Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
August 27, 2016
Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes
Yi-Lin Cheng, Yee-Shin Lin, Chia-Ling Chen, et al.
Veterinary Journal (London, England : 1997)
|
May 16, 2015
Direct coating of culture medium from cells secreting classical swine fever virus E2 antigen on ELISA plates for detection of E2-specific antibodies
Ta-Chun Cheng, Chu-Hsiang Pan, Chien-Shu Chen, et al.
Cancer Research
|
April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function
Xixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
Cancer Research
|
January 28, 2012
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells
Li-Yuan Chang, Yung-Chang Lin, Jayashri Mahalingam, et al.
American Journal of Cancer Research
|
April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells
Ye Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
American Journal of Cancer Research
|
March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer
Yu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer
Ching-Fei Li, Li-Yuan Bai, Yongkun Wei, et al.
The Journal of Biological Chemistry
|
March 12, 2022
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
Jong-Ho Cha, Li-Chuan Chan, Ying-Nai Wang, et al.
Nature Cancer
|
October 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, et al.
Nature Communications
|
November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Lei Nie, Yongkun Wei, Fei Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
August 27, 2016
Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes
Yi-Lin Cheng, Yee-Shin Lin, Chia-Ling Chen, et al.
Veterinary Journal (London, England : 1997)
|
May 16, 2015
Direct coating of culture medium from cells secreting classical swine fever virus E2 antigen on ELISA plates for detection of E2-specific antibodies
Ta-Chun Cheng, Chu-Hsiang Pan, Chien-Shu Chen, et al.
Cancer Research
|
April 6, 2022
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function
Xixi Zhao, Yongkun Wei, Yu-Yi Chu, et al.
Cancer Research
|
January 28, 2012
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells
Li-Yuan Chang, Yung-Chang Lin, Jayashri Mahalingam, et al.
American Journal of Cancer Research
|
April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells
Ye Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
American Journal of Cancer Research
|
March 21, 2020
Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer
Yu-Yi Chu, Clinton Yam, Mei-Kuang Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
All-trans retinoic acid-mediated ADAR1 degradation synergizes with PD-1 blockade to suppress pancreatic cancer
Ching-Fei Li, Li-Yuan Bai, Yongkun Wei, et al.
The Journal of Biological Chemistry
|
March 12, 2022
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
Jong-Ho Cha, Li-Chuan Chan, Ying-Nai Wang, et al.
Nature Cancer
|
October 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, et al.
Nature Communications
|
November 10, 2019
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Lei Nie, Yongkun Wei, Fei Zhang, et al.
Page
of 4